- Investing.com
Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Metrics to compare | NAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNANPeersSector | |
---|---|---|---|---|
P/E Ratio | 65.2x | −6.0x | −0.7x | |
PEG Ratio | 1.10 | 0.02 | 0.00 | |
Price/Book | 6.4x | 2.9x | 2.6x | |
Price / LTM Sales | 6.8x | 5.8x | 3.4x | |
Upside (Analyst Target) | 4.7% | 70.0% | 35.5% | |
Fair Value Upside | Unlock | −0.6% | 3.3% | Unlock |